Life Quality Study for PFAPA Patient

Completed

• Conditions: PFAPA Syndrome
• Interventions: Other: Quality of life

• Registration Number: NCT02811705
• Lead Sponsor: Versailles Hospital

Brief Summary

This cohort study aims to assess the quality of life (or welfare) related to the health of children and adolescents with an non genetics auto-inflammatory disease PFAPA or Marshall syndrome to compare it to children or adolescents with recurrent fever genetics of Familial Mediterranean fever (FMF) in order to improve their overall care.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-07
• Study First Submitted: 2016-06-15
• Study First Submitted QC: 2016-06-22
• Study First Posted: 2016-06-23
• Primary Completion: 2016-12
• Study Completion: 2017-04
• Status Verified: 2023-02
• Last Update Submitted: 2023-02-06
• Last Update Posted: 2023-02-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• PFAPA syndrome patients or FMF patients

Exclusion Criteria

• Participation refusal

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
PFAPA group	Quality of life	Life quality for PFAPA patient report by themselves or parent
FMF group	Quality of life	Life quality for FMF patient report by themselves or parent

Primary Outcome Measures

Name	Time	Method
Compare quality of life from patients with PFAPA and FMF, reported by parents and by patients themselves	1 day

Secondary Outcome Measures

Name	Time	Method
Evaluate the fatigue status of patients through questionnaire PedsQL TM 3.0 multidimensional scale tiredness	1 day

Trial Locations

Locations (2)

Centre hospitalier de Versailles; 🇫🇷 Le Chesnay, France

CH de Bicètre; 🇫🇷 Paris, France